Ered: In fact, E2V 2 mg EE is the Lenvatinib E7080 same as 10 mg. Due to the complexity of t of the methodology, we conducted our study over six cycles of OC administration. To an l Use Ngere not time, we thought we k Nnten to observe many dropouts, so we are not sufficient numbers of women to perform a statistical analysis would have had. In general, six cycles of oral contraceptives enough to make statistical analyzes of the women on the pill. This hypothesis is supported by several studies that support uses Similar number of treatment cycles. One aspect that our study the effect of OC examined E2V/DNG Lebensqualit t with the SF-36. The women reported an improvement in the r The physical, vitality r t, mental health, social functioning, and scales Emotional at the third cycle, and also the k Rperlichen function, general health and less k Rperliche pain in the sixth cycle. Women on oral contraceptives are usually exposed to the improvement of Lebensqualit t, which Ausma and aspects, depending on dosage and duration of application connections. Currently, k Can women oral ARQ 197 c-Met Inhibitors contraceptives in a subjective, flexible to use. The CB Scheme is an important aspect to consider. Stability of t a l Ngeren cycle with CO HFI reduced fee may be reached k Positive impact on nnte The quality of life T by reducing the sexual symptom produce My pr Menstrual bleeding and lower. In our study, the quality of t of women’s lives improved E2V/DNG fa Similar to women in the past CO will expand the system. The sexuality T judged by women on OC E2V/DNG by QBIC, gradually increased Ht, enjoyment, excitement, enhance orgasm, and desire, the third monitoring cycle. In addition, the monitoring of the sixth cycle were playing pass and wish h Get her in as the third cycle. The H FREQUENCY Of sexual activity T remained almost unchanged Changed, underscores the fact that often, birth control pills by erh Increase of subjective sexual satisfaction t H FREQUENCY of sexual activity T work. The evidence must be used to demystify the expectations are not always true that women have when they are on the OC. Accordingly, the Executive Board should focus on the Ver Persist through changes in contraceptive sexual Lebensqualit t and not on the H He made the sexual experience, it depends h Often of the relationship. One of the criteria for inclusion in our survey was that women in the study had the same thing, and only one sexual partner may need during the entire study period. In addition, the women had a good relationship with their partner and not by sexual dysfunction were evaluated before and w Affected during the study. These aspects were both the interview and sexual positions R.7 R.1 and R.10 examined by QBIC. Another interesting aspect of our study showed, is the apparent reduction of genital pain associated with reports in the third round, joined and followed in all six women with dyspareunia before Vinorelbine taking OC. We excluded women with PVD, the current vaginosis, vaginitis, and dystrophic. Each of these needs, a specific treatment before the start of the OC. However, if the woman is suffering from dyspareunia OC use, the pain may be dissolved by a topical hormone treatment Be st. In fact, since the CO is not able to relieve the symptoms of l Sen, k Nnten women, the data, the results of our study influenced h Tte reported. On the other hand, we have considered the effect of OC on dyspa.